niacinamide has been researched along with Allergy, Drug in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Linauskiene, K | 1 |
| Malinauskiene, L | 1 |
| Vitkauskaite, E | 1 |
| Chomiciene, A | 1 |
| Blaziene, A | 1 |
| Simonelli, M | 1 |
| Zucali, PA | 1 |
| Lorenzi, E | 1 |
| Rubino, L | 1 |
| De Vincenzo, F | 1 |
| De Sanctis, R | 1 |
| Perrino, M | 1 |
| Mancini, L | 1 |
| Di Tommaso, L | 1 |
| Rimassa, L | 1 |
| Masci, G | 1 |
| Zuradelli, M | 1 |
| Suter, MB | 1 |
| Bertossi, M | 1 |
| Fattuzzo, G | 1 |
| Giordano, L | 1 |
| Roncalli, MG | 1 |
| Santoro, A | 1 |
| Dotsenkov, VA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I and Pharmacokinetics Study of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors[NCT00984425] | Phase 1 | 30 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for niacinamide and Allergy, Drug
| Article | Year |
|---|---|
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Dose-Response Rela | 2013 |
2 other studies available for niacinamide and Allergy, Drug
| Article | Year |
|---|---|
Severe adverse skin reaction and desensitization to sorafenib.
Topics: Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Growth Processes; Desensitization, Imm | 2016 |
[Indices of the vitamin C, P, B1, B6 and PP allowances in experimental chromium sensitization].
Topics: Animals; Ascorbic Acid; Chromium; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Fl | 1978 |